EC approves Opdivo + Yervoy regimen for advanced melanoma
The European Commission (EC) has approved Bristol-Myers Squibb’s Opdivo in combination with Yervoy for the treatment of advanced (unresectable or metastatic) melanoma in adults.
Click on this link for more information.
